Literature DB >> 9261530

Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine.

R Advani1, R Warnke, B I Sikic, S Horning.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9261530     DOI： 10.1023/a:1008275208592

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells?

Authors:  Karen L Grogg; Ayoma D Attygalle; William R Macon; Ellen D Remstein; Paul J Kurtin; Ahmet Dogan
Journal:  Blood       Date:  2005-08-15       Impact factor: 22.113

2.  Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Authors:  Nathalie Mourad; Nicolas Mounier; Josette Brière; Emmanuel Raffoux; Alain Delmer; Alfred Feller; Chris J L M Meijer; Jean-François Emile; Réda Bouabdallah; André Bosly; Jacques Diebold; Corinne Haioun; Bertrand Coiffier; Christian Gisselbrecht; Philippe Gaulard
Journal:  Blood       Date:  2008-02-21       Impact factor: 22.113

3.  Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.

Authors:  Massimo Federico; Thomas Rudiger; Monica Bellei; Bharat N Nathwani; Stefano Luminari; Bertrand Coiffier; Nancy L Harris; Elaine S Jaffe; Stefano A Pileri; Kerry J Savage; Dennis D Weisenburger; James O Armitage; Nicholas Mounier; Julie M Vose
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

4.  Analysis of clinical characteristics and prognostic factors for angioimmunoblastic T-cell lymphoma.

Authors:  Yoshihiro Kameoka; Naoto Takahashi; Shigeki Itou; Masaaki Kume; Hideyoshi Noji; Yuichi Kato; Yoshikazu Ichikawa; Osamu Sasaki; Mutsuhito Motegi; Atsushi Ishiguro; Hiroyuki Tagawa; Kenichi Ishizawa; Yoji Ishida; Ryo Ichinohasama; Hideo Harigae; Kenichi Sawada
Journal:  Int J Hematol       Date:  2015-03-05       Impact factor: 2.319

5.  Cyclosporine, prednisone, and high-dose immunoglobulin treatment of angioimmunoblastic T-cell lymphoma refractory to prior CHOP or CHOP-like regimen.

Authors:  Xing-Gui Chen; He Huang; Ying Tian; Cheng-Cheng Guo; Chao-Yong Liang; Yao-Ling Gong; Ben-Yan Zou; Rui-Qing Cai; Tong-Yu Lin
Journal:  Chin J Cancer       Date:  2011-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.